The enhancement of immune function and activation of NF-κB by resveratrol-treatment in immunosuppressive mice

International Immunopharmacology

Volumn 33, Issue , 2016, Pages 42-47

  Lai, Xin ^a   Pei, Qingsheng ^b   Song, Xu ^a   Zhou, Xun ^a   Yin, Zhongqiong ^a   Jia, Renyong ^a   Zou, Yuanfeng ^a   Li, Lixia ^a   Yue, Guizhou ^a   Liang, Xiaoxia ^a   Yin, Lizi ^a   Lv, Cheng ^a   Jing, Bo ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b Qinghai Acad of Anim and Vet Med   (China)

Author keywords

Immune function; Immunosuppressive mice; NF B; Resveratrol

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; LEVAMISOLE; PUMA PROTEIN; RESVERATROL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STILBENE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; IMMUNITY; IMMUNOSTIMULATION; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLEEN LYMPHOCYTE; YOUNG ADULT; ANIMAL; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECTS; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNITY; IMMUNIZATION; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; MACROPHAGES, PERITONEAL; MALE; MICE; NF-KAPPA B; STILBENES;

EID: 84960938476     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.01.028     Document Type: Article

References (31)

1. P. Bagul, and S. Banerjee Application of resveratrol in diabetes: rationale, strategies and challenges Current Molecular Medicine. 2015
2. B.S. Gordon, D.C. Delgado-Diaz, J. Carson, R. Fayad, L.B. Wilson, and M.C. Kostek Resveratrol improves muscle function but not oxidative capacity in young mdx mice Can. J. Physiol. Pharmacol. 92 2014 243 251
3. H.-S. Liu, C.-E. Pan, W. Yang, and X.-M. Liu Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice World J. Gastroenterol. 9 2003 1474 1476
4. A.A. Qureshi, X.Q. Guan, J.C. Reis, C.J. Papasian, S. Jabre, D.C. Morrison, and et al. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor Lipids Health Dis. 11 2012 76
5. S.-L. Wu, Z.-J. Sun, L. Yu, K.-W. Meng, X.-L. Qin, and C.-E. Pan Effect of resveratrol and in combination with 5-FU on murine liver cancer World J. Gastroenterol. 10 2004 3048 3052
6. M.Z. Tang, Z.Z. Hong, L.I. Xiang-Yang, Z. Yang, Y.F. Wang, X.H. Wang, and et al. Immunomodulatory function study of resveratrol on immune system in rats Modern Journal of Integrated Traditional Chinese & Western Medicine 2005
7. P. Boscolo, S.A.E. Del, M. DG, G.L. Di, M. Reale, P. Conti, and et al. Effects of resveratrol on lymphocyte proliferation and cytokine release Ann. Clin. Lab. Sci. 33 2003 226 231
8. M.X. Wei, T. Tamiya, M. Chase, E.J. Boviatsis, T.K. Chang, N.W. Kowall, and et al. Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene Hum. Gene Ther. 5 1994 969 978
9. K. Antman, L. Ayash, A. Elias, C. Wheeler, M. Hunt, J. Eder, and et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy J. Clin. Oncol. 10 1992 102 110
10. S. Brode, and A. Cooke Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide Critical Reviews (tm) in Immunology 28 2008
11. Induces VETTG Down-regulation of the antitumor immune response Adv. Cancer Res. 45 1985 1
12. B.H. Hahn, L. Knotts, M. Ng, and T.R. Hamilton Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice Arthritis Rheum. 18 1975 145 152
13. B.M. Frey Mechanism of action of immunosuppressive agents Therapeutische Umschau Revue Thérapeutique 50 1993
14. G. Renoux, M. Renoux, M. Teller, S. McMahon, and J. Guillaumin Potentiation of T-cell mediated immunity by levamisole Clin. Exp. Immunol. 25 1976 288
15. J. Zulman, J. Michalski, C. Mccombs, J. Greenspan, and N. Talal Levamisole maintains cyclophosphamide-induced remission in murine lupus erythematosus Clin. Exp. Immunol. 31 1978 321 327
16. J.T. Carpenter, R.V. Smalley, M. Raney, C.L. Vogel, and R.S. Weiner Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group Trial Cancer Treatment Reports. 70 1986 1073 1079
17. S. Vallabhapurapu, and M. Karin Regulation and function of NF-κB transcription factors in the immune system Annu. Rev. Immunol. 27 2009 693 733
18. A.S. Baldwin The NF-κB and IκB proteins: new discoveries and insights Annu. Rev. Immunol. 14 1996
19. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
20. H. Yuan, J. Song, X. Li, N. Li, and J. Dai Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides Cancer Lett. 243 2006 228 234
21. M.R. Vachana Murunikkara Trikatu, an herbal compound as immunomodulatory and anti-inflammatory agent in the treatment of rheumatoid arthritis - an experimental study Cell. Immunol. 287 2014
22. T. Akasaka, K.-i. Tsuji, H. Kawahira, M. Kanno, K.-i. Harigaya, L. Hu, and et al. The role of mel-18, a mammalian polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors Immunity 7 1997 135 146
23. J. Punt Adaptive immunity: T cells and cytokines - cancer immunotherapy (second edition) - chapter 4 Cancer Immun. 41-53 2013
24. X. Gao, Y.X. Xu, N. Janakiraman, R.A. Chapman, and S.C. Gautam Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production Biochem. Pharmacol. 62 2001 1299 1308
25. S.H. Tsai, S.Y. Lin-Shiau, and J.K. Lin Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol Br. J. Pharmacol. 126 1999
26. V. Radkar, D. Hardej, C. Lau-Cam, and B. Billack Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells, and skin cells Arch. Ind. Hyg. Toxicol. 58 2007 293 304
27. S. Sakaguchi Naturally arising Foxp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self Nat. Immunol. 6 2005 345 352
28. R. Falchetti, M.P. Fuggetta, G. Lanzilli, M. Tricarico, and G. Ravagnan Effects of resveratrol on human immune cell function Life Sci. 70 2001 81 96
29. T. Zou, Y. Yang, F. Xia, A. Huang, X. Gao, D. Fang, and et al. Resveratrol inhibits CD4 + T cell activation by enhancing the expression and activity of Sirt1 PLoS One 8 2013 e75139
30. A.A. Bertelli, R. Baccalini, E. Battaglia, M. Falchi, and M.E. Ferrero Resveratrol inhibits TNF alpha-induced endothelial cell activation Thérapie. 56 2001 613 616
31. M. Qiang, K. Krista, Y. Jianping, and J.C. Bruce Inhibition of nuclear factor kappaB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression Mol. Pharmacol. 64 2003 211 219